2016
DOI: 10.1016/j.bmcl.2016.06.016
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological activity of novel ester derivatives of N3-(4-metoxyfumaroyl)-(S)-2,3-diaminopropanoic acid containing amide and keto function as inhibitors of glucosamine-6-phosphate synthase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 13 publications
0
8
0
Order By: Relevance
“…For the GAT domain in C. albicans , the crystal structure has not been reported. But all amino acids forming the glutamine binding site are completely conserved in both E. coli and C. albicans enzymes; therefore, the available structure of the prokaryotic GlcN-6-P synthase (PDB code 1GMS) was always used as the receptor model. , The crystal structure of ISOM domain of GlcN-6-P synthase in C. albicans was reported by Rypniewski and co-workers in 2007 (PDB code 2POC, Figure B–D) …”
Section: Antifungals Targeting the Cell Wallmentioning
confidence: 99%
“…For the GAT domain in C. albicans , the crystal structure has not been reported. But all amino acids forming the glutamine binding site are completely conserved in both E. coli and C. albicans enzymes; therefore, the available structure of the prokaryotic GlcN-6-P synthase (PDB code 1GMS) was always used as the receptor model. , The crystal structure of ISOM domain of GlcN-6-P synthase in C. albicans was reported by Rypniewski and co-workers in 2007 (PDB code 2POC, Figure B–D) …”
Section: Antifungals Targeting the Cell Wallmentioning
confidence: 99%
“…albicans suggests that the use of more lipophilic formulations of conjugates while slightly scarifying the biocompatibility toward mammalian cells might be a better strategy for more efficient nanoparticle internalization by fungal cells. Similar strategies were very recently adopted for the development of lipophilic FMDP prodrugs that have already proven the applicability of the high lipophilicity concept. , …”
Section: Results and Discussionmentioning
confidence: 99%
“…Similar strategies were very recently adopted for the development of lipophilic FMDP prodrugs that have already proven the applicability of the high lipophilicity concept. 40,41 The current results obtained for the GlcN-6-P synthase targeting by the nanomedical approach further complicate the antifungal therapy expectations. The results were in conflict with the previously reported nontoxic in vitro activity of FMDP−peptide conjugates against human cell lines.…”
Section: Langmuirmentioning
confidence: 99%
“…As shown in Figure 1, currently the development of antifungal compounds based on GlcN-6-P synthase has been carried out. Derivatives of N 3 -(4-methoxyfumaroyl)-(S)-2,3diaminopropanoic acid (FMDP) which have great antifungal activities targeted GlcN-6-P synthase have been synthesized, including compounds 4, 5, 11, 12, and 13 (mentioned in this review is FMDP derivatives 1, 2, 3, 4, and 5), with MIC of 4, 32, 0.25, 0.5, and 0.5 µg/ml, respectively (Pawlak et al, 2015(Pawlak et al, , 2016. These findings indicated the significance of exploiting GlcN-6-P synthase inhibitors for antifungal treatment, and we believe that there will be more new effective antifungal drugs produced based on this target.…”
Section: Glucosamine-6-phosphate Synthasementioning
confidence: 99%